$IDYA surged 14% after positive trial results in rare eye cancer,showing progression-free survival improved to 6.9 vs. 3.1 months.The treatment targets uveal melanoma and is being co-developed with Servier
Could this breakthrough reshape the outlook for biotech cancer therapies?
Bank earnings (GS, JPM, BAC) lead this week, alongside TSMC, ASML, and Netflix, while key data on housing, inflation, and jobs come as energy costs stay high amid the Iran war
#GS#JPM#BAC#TSMC#ASML
On Thursday, the U.S.-Iran ceasefire held steady, and the three major indices posted modest gains, driving strength in technology stocks; meanwhile, oil prices rebounded following a sharp decline the previous day
U.S.February PCE data is expected to come in above forecasts,with a rebound in goods prices excluding energy emerging as a new driver of inflation. As inflation continues to run above the 2% target,the Federal Reserve may hold rates steady for a third consecutive meeting in April